Form 8-K - Current report:
SEC Accession No. 0000318306-14-000041
Filing Date
2014-12-03
Accepted
2014-12-03 17:10:15
Documents
2
Period of Report
2014-12-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K r8k-550.htm 8-K 27068
2 UNSECURED GRID NOTE DATED DECEMBER 1, 2014 ex_10-35.htm EX-10.35 136411
  Complete submission text file 0000318306-14-000041.txt   164990
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
PLASMATECH BIOPHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 141264113
SIC: 2834 Pharmaceutical Preparations